Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/01/2009US20090247615 TRIGGERED RNAi
10/01/2009US20090247614 Folate Conjugates
10/01/2009US20090247613 Chemically synthesized nucleic acid molecule with a pyrimidine modification; cancer, ocular disease, and other proliferative disorders; neovascularization, diabetic retinopathy, restenosis and polycystic kidney disease
10/01/2009US20090247612 Prevention of viral infectivity
10/01/2009US20090247611 Method of treating a cancer with a survivin antisense oligonucleotide and paclitaxel
10/01/2009US20090247610 Integrase cofactor
10/01/2009US20090247609 Sm-protein based secretion engineering
10/01/2009US20090247608 Targeting Lipids
10/01/2009US20090247607 dsRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTION
10/01/2009US20090247606 RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
10/01/2009US20090247605 Treating diseases mediated by metalloprotease-shed proteins
10/01/2009US20090247604 RNAi Therapeutics for Treatment of Eye Neovascularization Diseases
10/01/2009US20090247603 Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor
10/01/2009US20090247602 Cosmetic use of conjugated compounds of indolic auxins
10/01/2009US20090247601 Peptide derivatives with therapeutic activity
10/01/2009US20090247600 Remedy for corneal diseases
10/01/2009US20090247599 Methods of treating cell proliferative disorders using a compressed temozolomide dosing schedule
10/01/2009US20090247598 Treatment methods
10/01/2009US20090247596 Thiophenecarboxamide derivatives as ep4 receptor ligands
10/01/2009US20090247595 Process for the preparation of tetrazolyl compounds
10/01/2009US20090247594 Therapeutic compounds
10/01/2009US20090247593 N-thiazol-2-yl-benzamide derivatives
10/01/2009US20090247592 Epothilones C, D, E, and F, Preparation and Compositions
10/01/2009US20090247591 Substituted cyclohexyldiamines
10/01/2009US20090247590 Indane amides
10/01/2009US20090247589 Monocarboxylates for modifying macrophage function
10/01/2009US20090247588 2-trifluoromethylnicotinamide derivatives as hdl-cholesterol raising agents
10/01/2009US20090247587 1,3-dihydroisobenzofuran derivatives
10/01/2009US20090247585 Pharmaceutical composition comprising, in combination, saredutant and escitalopram
10/01/2009US20090247584 Phenoxy-piperidines for the treatment of diseases such as schizophrenia and depression
10/01/2009US20090247583 Pharmaceutical composition comprising, in combination, saredutant and paroxetine
10/01/2009US20090247582 Methods of treating atherosclerosis
10/01/2009US20090247581 Organic Compounds
10/01/2009US20090247580 Nitroxide radioprotector formulations and methods of use
10/01/2009US20090247579 2-[3h-thiazol-2-ylidinemethyl]pyridines and related compounds and their use
10/01/2009US20090247578 5-hydroxymethyl-oxazolidin-2-one-derivatives and their uses as antibacterials
10/01/2009US20090247577 Pyrrolidine derivatives useful as bace inhibitors
10/01/2009US20090247576 Anti-tumor agent for multiple myeloma
10/01/2009US20090247575 Stabilizing lipid compositions for oral pharmaceutical agents
10/01/2009US20090247574 3-amino-pyridine derivatives for the treatment of metabolic disorders
10/01/2009US20090247573 (hetero)aryl cyclohexane derivatives
10/01/2009US20090247572 Agent for treating atrial fibrillation
10/01/2009US20090247571 Certain Chemical Entities, Compositions and Methods
10/01/2009US20090247570 Pharmaceuticals
10/01/2009US20090247569 Process for Preparing Clopidogrel Bisulphate
10/01/2009US20090247568 Aminopiperidinyl derivatives and uses thereof
10/01/2009US20090247567 Benzopyran and benzoxepin pi3k inhibitor compounds and methods of use
10/01/2009US20090247566 Pyrano [3,2-C] Pyridones and Related Heterocyclic Compounds as Pharmaceutical Agents for Treating Disorders Responsive to Apoptosis, Antiproliferation or Vascular Disruption, and the Use Thereof
10/01/2009US20090247565 receptor tyrosine kinase MET inhibitors; anticancer agents; 8-phenyl-10H-furo[2',3':4,5]cyclohepta[1,2-b]pyridin-10-one
10/01/2009US20090247564 Crystalline Form of Vinflunine Ditartrate
10/01/2009US20090247563 asymmetric production of 3-(pyridin-4-yl)-3-hydroxy-pentanoic acid derivatives; for preperation of manufacture of homocamptothecins antiproliferative agents
10/01/2009US20090247562 Large substituent, non-phenolic opioids and methods of use thereof
10/01/2009US20090247561 Substituted spirocyclic cyclohexane derivatives
10/01/2009US20090247560 Diaryl ketimine derivative
10/01/2009US20090247559 Benzofuropyrimidinones
10/01/2009US20090247558 Use of the crh (corticotropin releasing hormone) - ucn (urocortin) system in the treatment of inflammatory diseases
10/01/2009US20090247557 Partial and full agonists of a1 adenosine receptors
10/01/2009US20090247556 Azolopyrimidines as Inhibitors of Cannabinoid 1 Activity
10/01/2009US20090247555 5,7-Disubstituted[1,3]Thiazolo[4,5-D]Pyrimidin-2(3H)-One Derivatives 258
10/01/2009US20090247554 Kinase inhibitors
10/01/2009US20090247553 Highly Pure Paliperidone or a Pharmaceutically Acceptable Salt Thereof Substantially Free of Keto Impurity
10/01/2009US20090247552 Aqueous liquid preparation containing amide compound
10/01/2009US20090247550 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as hdl-cholesterol raising agents
10/01/2009US20090247549 Methods of using saha and bortezomib for treating cancer
10/01/2009US20090247548 Pyrrolopyrimidine derivatives for treating proliferative diseases
10/01/2009US20090247547 Hydroxamate-based inhibitors of deacetylases b
10/01/2009US20090247546 Treatment of Prevention of Valvular Heart Disease with Flibanserin
10/01/2009US20090247545 Substituted oxazolidinone derivatives
10/01/2009US20090247544 Certain Chemical Entities, Compositions and Methods
10/01/2009US20090247543 Gatifloxacin-containing aqueous liquid preparation
10/01/2009US20090247542 Syntheses and preparations of polymorphs of crystalline aripiprazole
10/01/2009US20090247541 Novel compounds
10/01/2009US20090247540 Peptide and small molecule agonists of epha and their uses
10/01/2009US20090247539 Novel Pharmaceuticals
10/01/2009US20090247538 Ortho-Condensed Pyridine and Pyrimidine Derivatives (e.g., Purines) as Protein Kinases Inhibitors
10/01/2009US20090247537 Methods for preventing or treating bruxism using dopaminergic agents
10/01/2009US20090247536 Bissulfonamide Compounds As Agonists Of GalR1, Compositions, And Methods Of Use
10/01/2009US20090247535 Use of ranolazine for non-cardiovascular disorders
10/01/2009US20090247534 New compounds
10/01/2009US20090247533 Ecteinascidins
10/01/2009US20090247532 Crystalline polymorph of sitagliptin phosphate and its preparation
10/01/2009US20090247531 CRYSTALLINE FORMS OF [(1R), 2S]-2-AMINOPROPIONIC ACID 2-[4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-5-METHYLPYRROLO[2,1-f][1,2,4]TRIAZIN-6-YLOXY]-1-METHYLETHYL ESTER
10/01/2009US20090247530 Substituted 4-aminocyclohexane derivatives
10/01/2009US20090247529 Topical compositions
10/01/2009US20090247528 Method of treating attention deficit disorder
10/01/2009US20090247527 Substituted gamma lactams as therapeutic agents
10/01/2009US20090247526 Glucokinase activators
10/01/2009US20090247525 Sigma receptor inhibitors
10/01/2009US20090247524 HSP90 Inhibitor
10/01/2009US20090247523 Carboxamide 4-[(4-pyridyl)amino]pyrimidines useful as hcv inhibitors
10/01/2009US20090247522 Hsp90 FAMILY PROTEIN INHIBITORS
10/01/2009US20090247521 Soluble epoxide hydrolase inhibitors for the treatment of endothelial dysfunction
10/01/2009US20090247520 INHIBITORS OF ANTIGEN RECEPTOR-INDUCED NF-kappa B ACTIVATION
10/01/2009US20090247519 Amino-ethyl-amino-aryl (aeaa) compounds and their use
10/01/2009US20090247518 6-(2-alkyl-phenyl)-pyrido[2,3-d]pyrimidines useful as protein kinase inhibitors
10/01/2009US20090247517 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
10/01/2009US20090247516 3- (benzo [d] [1,3] dioxol-5-ylmethyl) -4- (thio) oxo-2- (thio) oxo-azolidin-5-ylidene derivatives as antibacterial agents
10/01/2009US20090247515 11 Beta-HSD1 Modulators
10/01/2009US20090247514 Spirolactam aryl cgrp receptor antagonists
10/01/2009US20090247513 Benzothiophene compounds having antiinfective activity
1 ... 2553 2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 2569 2570 2571 2572 2573 ... 7860